Skip to main content

Table 6 Healthcare resources and other resources utilization by individuals who reported self-medication with cannabis in an online survey in Quebec from November 2020 to January 2021 (n = 489)

From: A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada

 

Gender

Age (years)

Type of cannabis use

Total participants (n = 489) N (%)a

Men

Women

p-value$

≤34

>34

p-value$

Medical use only (n = 122)

Medical + recreational use (n = 367)

p-value$

Treated condition(s) were diagnosed

N= 232

N= 234

0.050

N= 248

N= 233

<.0001

N= 120

N= 362

0.0009

N= 482

 Yes, all treated conditions

95 (40.95)

122 (52.14)

 

86 (34.68)

135 (57.94)

 

73 (60.83)

149 (41.16)

 

222 (46.06)

 Yes, but not all treated conditions

85 (36.64)

72 (30.77)

 

97 (39.11)

67 (28.76)

 

29 (24.17)

135 (37.29)

 

164 (34.02)

 No

52 (22.41)

40 (17.09)

 

65 (26.21)

31 (13.30)

 

18 (15.00)

78 (21.55)

 

96 (19.92)

Declaration of cannabis use to healthcare professionalsc

N = 191

N = 151

0.1345

N = 170

N = 180

0.0276

N = 90

N = 261

0.034

N= 351

 Yes, always

111 (58.12)

72 (47.68)

 

78 (45.88)

107 (59.44)

 

51 (56.67)

135 (51.72)

 

186 (52.99)

 Yes, sometimes

56 (29.32)

52 (34.44)

 

65 (38.24)

47 (26.11)

 

20 (22.22)

92 (35.25)

 

112 (31.91)

 No

24 (12.57)

27 (17.88)

 

27 (15.88)

26 (14.44)

 

19 (21.11)

34 (13.03)

 

53 (15.10)

Resources consulted for cannabis use

N = 235

N = 238

 

N = 252

N = 236

 

N = 122

N = 367

 

N = 489

 Physician

87 (37.02)

51 (21.43)

0.0002

67 (26.59)

75 (31.78)

0.2070

34 (27.87)

109 (29.70)

0.700

143 (29.24)

 Pharmacist

19 (8.09)

17 (7.14)

0.70

21 (8.33)

15 (6.36)

0.4037

9 (7.38)

27 (7.36)

0.99

36 (7.36)

 Legal recreational cannabis store agent

73 (31.06)

102 (42.86)

0.0079

85 (33.72)

95 (40.25)

0.1355

53 (43.44)

127 (34.60)

0.079

180 (36.81)

 Illegal seller

25 (10.64)

18 (7.56)

0.24

27 (10.71)

18 (7.63)

0.2388

6 (4.92)

39 (10.63)

0.059

45 (9.20)

 Agent from a cannabis production company

18 (7.66)

13 (5.46)

0.33

15 (5.95)

17 (7.20)

0.5769

10 (8.20)

22 (5.99)

0.39

32 (6.54)

 Psychologist or psychotherapist

26 (11.06)

15 (6.30)

0.066

25 (9.92)

16 (6.78)

0.2113

9 (7.38)

32 (8.72)

0.64

41 (8.38)

 Naturopath or herborist

9 (3.83)

6 (2.52)

0.42

9 (3.57)

7 (2.97)

0.7075

4 (3.28)

12 (3.27)

0.99

16 (3.27)

 Other resourcesa

31 (13.19)

20 (8.40)

0.093

24 (9.52)

31 (13.14)

0.2074

19 (15.57)

36 (9.81)

0.081

55 (11.25)

 Never consulted

88 (37.45)

98 (41.18)

0.406

108 (42.86)

83 (35.17)

0.0821

39 (31.97)

152 (41.42)

0.064

191 (39.06)

Information sought by consulting a resource (n = 298 as 191 never consulted a resource)

N = 147

N = 140

 

N = 144

N = 153

 

N = 83

N = 215

 

N = 298

 Methods of cannabis consumption

28 (19.05)

45 (32.14)

0.011

36 (25.00)

38 (24.84)

0.9740

28 (33.73)

46 (21.40)

0.027

74 (24.83)

 Available varieties and concentrations/potencies of cannabis products

69 (46.94)

85 (60.71)

0.027

78 (54.17)

84 (54.90)

0.8988

47 (56.63)

115(53.49)

0.626

162 (54.36)

 Efficacy of cannabis

78 (53.06)

86 (61.43)

0.152

85 (59.03)

85 (55.56)

0.5455

52 (62.65)

118 (54.88)

0.225

170 (57.05)

 Safety of cannabis/adverse effects

31 (21.09)

24 (17.14)

0.396

35 (24.31)

22 (14.38)

0.0299

17 (20.48)

41 (19.07)

0.783

58 (19.46)

 Safety to combine cannabis with other medication

35 (23.81)

37 (26.43)

0.609

36 (25.00)

40 (26.14)

0.8214

25 (30.12)

51 (23.72)

0.256

76 (25.50)

 Subjective effect of cannabis (‘high’)

33 (22.45)

23 (16.43)

0.198

42 (29.17)

18 (11.76)

0.0002

4 (4.82)

56 (26.05)

<0.0001

60 (20.13)

 Otherb

12 (8.16)

5 (3.57)

0.099

12 (8.33)

8 (5.23)

0.2860

4 (4.82)

16 (7.44)

0.417

20 (6.71)

Would like to have access to a healthcare professional regarding medical use of cannabis (n = 343; missing = 14)c

 Yes

146 (79.78)

122 (80.79)

0.82

136 (82.93)

139 (78.09)

0.2602

72 (80.00)

204 (80.63)

0.90

276 (80.47)

  1. Comparisons between groups were made using chi-square tests and p-value calculated. A p-value <0.05 was considered as statistically significant
  2. $See Supplemental Table 1 for pairwise comparisons for categorical variables with a significant global p-value
  3. aOther resources included friends/relative/other patients; Internet (Health Canada documentation, scientific articles, online forums), nurses, social worker, physiotherapist, and nutritionist
  4. bOther included substitution of cannabis with benzodiazepines and antidepressants, information on the medical access process, if their health condition could be treated with cannabis, risk of dependence with cannabis, information on the reimbursement by insurance, information on the endocannabinoid system, what to do in case of intoxication
  5. cThese variables were completed by a subset of the participants (n = 357) as these questions were added to the questionnaire after the start of the survey